Full Text
PDB39 - EMPAGLIFLOZIN FOR PATIENTS IN THE NETHERLANDS WITH TYPE 2 DIABETES MELLITUS AND ESTABLISHED CARDIOVASCULAR DISEASE- A BUDGET IMPACT MODEL

Abstract

Authors

M. Voorhaar L. Nurkanovic A.V. Ustyugova E. Dvortsin M.J. Postma

Back to Volume 21, Supplemental S3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×